These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 35274005)
1. Pan-Cancer Transcriptome and Immune Infiltration Analyses Reveal the Oncogenic Role of Far Upstream Element-Binding Protein 1 (FUBP1). Wang H; Zhang R; Li E; Yan R; Ma B; Ma Q Front Mol Biosci; 2022; 9():794715. PubMed ID: 35274005 [TBL] [Abstract][Full Text] [Related]
2. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer]. Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766 [No Abstract] [Full Text] [Related]
3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. Liu M; Zhao H; Peng S; Wu Y; Liu Y; Sun W; Zen K; Sun X FASEB J; 2024 Mar; 38(5):e23523. PubMed ID: 38457275 [TBL] [Abstract][Full Text] [Related]
5. Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis. Wang Y; Zhao Y; Zhang G; Lin Y; Fan C; Wei H; Chen S; Guan L; Liu K; Yu S; Fu L; Zhang J; Yuan Y; He J; Cai H Sci Rep; 2024 Oct; 14(1):24203. PubMed ID: 39406840 [TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
7. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
8. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171 [TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression. Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X Front Oncol; 2022; 12():927988. PubMed ID: 35756681 [TBL] [Abstract][Full Text] [Related]
10. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. Li L; Feng Q; Wang X Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050 [TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
12. A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets. Fu X; Ji F; He Q; Qiu X J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint. Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930 [TBL] [Abstract][Full Text] [Related]
14. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA. Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216 [TBL] [Abstract][Full Text] [Related]
15. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis. Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468 [TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis Revealed Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J J Oncol; 2022; 2022():3477148. PubMed ID: 35069733 [TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Molecular Characterization of m Zhu J; Xiao J; Wang M; Hu D Front Oncol; 2020; 10():618374. PubMed ID: 33585244 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis. Liu Y; Xue J; Zhong M; Wang Z; Li J; Zhu Y Front Mol Biosci; 2021; 8():692120. PubMed ID: 34395525 [No Abstract] [Full Text] [Related]
19. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers. Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L Front Oncol; 2022; 12():916907. PubMed ID: 35785154 [TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis of the role of Ding G; Ma T; Zhang K; Chen G; Shen J; Zhang S; Li K; Zhao C; Wang F; Sun J; Wang J Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1456-1471. PubMed ID: 36971139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]